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Simple Summary: Radiotherapy is an essential treatment modality for breast cancer. Compared to
conventional radiotherapy techniques, modern radiotherapy with fewer fractions and smaller target
volumes requires higher accuracy. Image-guidance using cone-beam computed tomography (CBCT)
is one of the most common methods used for positional verification before treatment. This study
reports geometric and dosimetric outcomes evaluated by analyzing CBCT images acquired before
and during treatments. The positional change and internal movement of the patient were less than
1 cm in most cases without significant deviation in the dosimetric parameters of interest. However,
there were cases involving extreme variation, which resulted in insufficient radiation delivered to the
target areas and increased radiation exposure to adjacent normal organs. The results of the current
study suggest that unexpected intra-fractional motion may occur, prompting for marginal adaptation
in selected patients who are deemed to suffer from this kind of event.
Abstract: With the introduction of modern sophisticated radiotherapy (RT) techniques, the signifi-
cance of accuracy has increased considerably. This study evaluated the necessity of pre-treatment and
intra-fractional cone-beam computed tomography (CBCT) by analyzing inter- and intra-fractional
CBCT images of breast cancer patients receiving RT. From 57 patients, 1206 pre-treatment CBCT and
1067 intra-fractional CBCT images were collected. Geometric movements of patients were measured
quantitively in both inter- and intra-fractional CBCT, and changes in dosimetric parameters were
evaluated in selected patients with extreme intra-fractional movement. For right-sided breast cancer
patients, left-sided breast cancer patients treated using deep-inspiration breath hold (DIBH), and
left-sided breast cancer patients treated using continuous positive airway pressure (CPAP), median
inter-fractional deviations were 0.53 (range 0.06–2.98) cm, 0.66 (range 0.08–4.41) cm, and 0.69 (range
0.04–3.80) cm, and median intra-fractional deviations were 0.14 (range 0.00–0.62) cm, 0.23 (range
0.02–0.96) cm, and 0.24 (0.00–1.15) cm, respectively. Modified plans reflecting large changes in intra-
fractional position in 10 selected cases revealed insufficient target coverage in seven cases and more
than 20-fold increase in the volume of heart receiving at least 25 Gy in two cases. Intra-fractional
verification, as well as pre-treatment verification, might be considered in patients using DIBH or
CPAP.
Keywords: cone-beam computed tomography; image-guided radiotherapy; volumetric modulated
arc therapy; breast cancer; intrafraction motion
1. Introduction
As modern radiation therapy (RT) with highly sophisticated techniques becomes
more widely used in treating cancer patients [1], ensuring RT accuracy is becoming more
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important than ever. Prominent characteristics of modern RT include increasing frequency
of intensity-modulated RT (IMRT) and stereotactic body RT (SBRT) with image-guidance. In
clinical practice, volumetric imaging modalities such as cone-beam computed tomography
(CBCT) and mega-voltage computed tomography are frequently used for pre-treatment
verifications [2]. IMRT shows benefits in target coverage with normal organ sparing,
whereas SBRT is characterized by very high dose delivery in a small number of fractions
to a restricted target area. However, the treatment time for each fraction increases due
to pre-treatment verification and the utilization of a complex treatment plan with multi-
directional beams. Longer treatment times may lead to extensive patient movement during
RT, which may alter the quality of actual RT delivery to the target area. To this end, many
studies have evaluated the effects of intra-fractional movement on dosimetric outcomes in
various organs and regions of the body, including prostate [3,4], lung [5,6], head and neck,
and abdomino-pelvic areas [7].
Conventionally, RT has been one of the most common treatment modalities used
when managing breast cancer. Despite its lengthy history of utilization, the current trends
in RT for breast cancer have been changing drastically. For example, there are wider
implications for hypofractionation [8,9] and the application of partial breast irradiation
(PBI) in selected patients with small target volumes [9,10]. Moreover, techniques such as
deep-inspiration breath hold (DIBH) and continuous positive airway pressure (CPAP) may
avoid heart toxicity when treating left-sided breast cancer. However, these techniques
may be physically challenging for some patients and may lead to a higher incidence
of inter- and intra-fractional positional error. To our best knowledge, studies regarding
the measurement of intra-fractional error in breast cancer patients with CBCT images
are not plenty. Therefore, this study evaluated the plausibility of employing not only
inter-fractional but also intra-fractional CBCT in clinical practice by analyzing inter- and
intra-fractional CBCT images of breast cancer patients with respect to positional changes
and subsequent dosimetric alterations.
2. Materials and Methods
2.1. Patients
The intra-fractional CBCT images of 57 patients treated in Gangnam Severance Hospi-
tal from June 2019 to November 2020 were collected. All patients underwent non-contrast
CT simulation in a supine position with a customized arm support using a breast board.
All patients received single, partial-arc volumetric modulated arc therapy (VMAT) with
pre-treatment verification using kV-CBCT. All VMAT plans used 6 MV coplanar photon
beams with a single isocenter for each patient and were designed using the RayStation
treatment planning system (TPS) (RaySearch Laboratories AB, Stockholm, Sweden). The
Versa HDTM linear accelerator (Elekta Limited, Stockholm, Sweden) equipped with a
multi-leaf collimator was used for RT. To spare critical organs at risk (OARs), patients with
left-sided breast cancer underwent either DIBH or CPAP to inflate the lungs and increase
the distance from the chest wall to the heart and coronary arteries. Patients with right-sided
breast cancer were treated without these particular techniques. The dose scheme for RT
was either the conventional regimen of 50.4 Gy for patients who received regional node
irradiation or a hypofractionated regimen of 40.05 Gy in 15 fractions for patients receiving
whole breast irradiation only. A bolus was applied for the initial 14 fractions to patients
who received radical mastectomy with reconstruction and was removed for the remaining
14 fractions to avoid excessive skin toxicity.
2.2. CBCT Data Acquisition
CBCT images were acquired daily at two time points: one before the treatment and
another during RT. After positioning the patient according to the three skin markers
drawn during simulation, pre-treatment CBCT images were acquired. For each fraction,
pre-treatment CBCT images were registered to simulation CT images by an automatic
configuration process followed by fine manual adjustment, if necessary, by the physician
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or therapist. During this configuration process, the chest wall and breast were the primary
points of interest while other reference structures such as bony spines were evaluated as
well to achieve an ideal treatment setup. In rare cases showing significant dislocation of
the breast even if the chest wall matched well, a treating physician decided the course of
action among several options which included continuing the treatment, repositioning the
patient, and conducting an adaptive CT simulation. All these corrections were executed by
mechanically adjusting the couch. During partial-arc VMAT, a simultaneous intra-fractional
CBCT scan was taken as the gantry rotated around the patient. The gantry rotation angle
(the initial position of the gantry indicated a benchmark of 0◦) for intra-fractional CBCT
acquisition ranged from −60◦ to 160◦ clockwise for left-sided breast cancer and −160◦ to
60◦ counterclockwise for right-sided breast cancer. A small field-of-view protocol using an
S20 collimator and F0 filter was utilized (120 kVp, 20 mA, and a 20 ms time period for each
projection).
2.3. Data Analysis
The change in position between CT simulation and the actual position of the patient
before and during RT was assessed by pre-treatment CBCT and intra-fractional CBCT,
respectively, according to the differences in x-, y-, and z-axes as shown in Figure 1. After
the difference in each axis was measured, the absolute distance between two CT images
was measured by the formula: √
∆x2 + ∆y2 + ∆z2.
The configuration process for intra-fractional CBCT was identical to pre-treatment
CBCT and was monitored by an experienced radiation oncologist and physicist. The chest
wall was used as the baseline standard for configuration, and the bony spine was used as a
supplemental benchmark. Ten fractions which showed the biggest deviations were selected.
From them, we created a virtual RT plan according to the measured differences between the
original CT simulation and the intra-fractional CBCT scan. New dose-volume histograms
(DVH) were acquired for the modified plan. All target volumes and normal organs were
contoured using MIM software version 6.6.14 (MIM Software, Inc., Cleveland, OH, USA),
and the DVHs for each plan were generated by RayStation TPS. OARs were delineated by
either an experienced radiation oncologist or dosimetrist. Clinical target volume of breast
or chest wall, and regional lymph nodes if necessary depending on treating physician’s
discretion, was contoured based on ESTRO consensus guideline [11]. Uniform set-up
margin of 2–3 mm, mostly 2 mm, was added to construct planning target volume (PTV).
Doses to the PTV, the lungs, and the heart were critical points of interest in this study. To
evaluate precise dose coverage and to avoid normal organs, the following DVH values
were collected: D95% of the PTV, V95% of the prescription dose, mean lung dose, V5 Gy of ipsilateral
lung, V20 Gy of the ipsilateral lung, D0.2 cc for the heart, and V25 Gy of the heart. D”volume”
indicated the cumulative dose to the most exposed “volume,” and V”dose” was defined
as the percentage of the total volume receiving a dose that exceeded the “dose.” At our
institution, the target coverage of a treatment plan was regarded ideal if both D95% of the PTV
and V95% of the prescription dose exceeded 95% of the prescription dose and 95% of the PTV,
respectively. The treatment plan was regarded as acceptable if these values were within the
90–95% range, and it was regarded as unacceptable if one of these values was below 90%. A
comparison of the extent of positional change from pre-treatment CBCT to intra-fractional
CBCT for each fraction was performed using the Wilcoxon signed-rank test. The Kruskal–
Wallis test and a subsequent Mann–Whitney U test were used to compare the extent of
movement according to location and RT technique. p-values of <0.05 for the Wilcoxon
signed-rank test and p-values of <0.017 for the Kruskal–Wallis test and Mann–Whitney
U test were considered statistically significant. All statistical analyses were performed
with IBM SPSS Statistics for Windows, Version 24.0 (IBM Corp., Armonk, NY, USA) and
GraphPad Prism for Windows, Version 8.4.3 (GraphPad Software, San Diego, CA, USA).
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3.1. Patients and Treatment 
Twenty right-sided breast cancer patients and 37 left-sided breast cancer patients 
were included in this study. Of the latter, 24 patients were treated using the DIBH tech-
nique, and 13 patients were treated using CPAP. The cumulative numbers of fractions per 
location and treatment technique were as follows: right-sided breast cancer = 413, pre-
treatment CBCT and 361, intra-fractional CBCT; left-sided breast cancer and use of DIBH 
= 561, pre-treatment and 484, intra-fractional CBCT; and left-sided breast cancer with the 
use of CPAP = 232, pre-treatment CBCT and 222, intra-fractional CBCT. 
The beam angle for the treatment of right-sided breast cancer ranged from 155° to 
172° counterclockwise. The starting point of the beam was between 50° and 60°, while the 
stopping point was between −130° and −150°. For left-sided breast cancer, the beam angle 
ranged from 169° to 190° clockwise. The starting point was between −45° and −50°, while 
the stopping point was between 124° and 140°. 
3.2. Pre-Treatment and Intra-Fractional CBCT 
Table 1 summarizes the range of motion (ROM) in centimeters by location and RT 
technique according to the x-, y-, and z-axes, as well as the absolute difference. For all 
locations and treatment techniques, larger ROMs were recorded for pre-treatment CBCT 
scan than for the corresponding intra-fractional CBCT scan. All comparisons of the abso-
lute differences between pre-treatment CBCT and intra-fractional CBCT scan were statis-
tically significant (p < 0.001). Therefore, the magnitude of the positional change is likely to 
be smaller on intra-fractional CBCT than on inter-fractional CBCT, regardless of location 
or the technique used. 
However, even though intra-fractional movement was less than its inter-fractional 
counterpart, there remain a few exceptions regarding significant positional changes. Fig-
ure 2A–D summarizes the intra-fractional ROM in right-sided breast cancer patients. Fig-
ure 3A–D displays the intra-fractional ROM in left-sided breast cancer patients treated 
using the DIBH technique. Figure 4A–D shows the intra-fractional ROM in left-sided 
Figure 1. Schematic description of patient set-up during radiotherapy and measurement method.
Each arrow shows the direction (plane) of measurement. The difference between the position of the
patient during simulation and the actual position of the patient during radiotherapy, as depicted
by the gold-colored body, was calculated by comparing simulation CT images with intra-fractional
CBCT images.
3. Results
3.1. Patients and Treatment
Twenty right-sided breast cancer patients a d 37 left-sid d breast cancer p tients were
includ d in this study. Of the latter, 24 patients were reat d using the DIBH techniqu ,
and 13 patients were treated using CPAP. The cumulative numbers of fractions pe location
and treatme t technique w re as follows: right-sided breast cancer = 413, pre-treatment
CBCT and 361, intra-fractio al CBCT; left-sided breast cancer nd use of DIBH = 561,
pre-treatmen and 484, i tra-fractional CBCT; and left-sided breast canc r with the use of
CPAP = 232, pre-treatmen CBCT and 222, intra-fractional CBCT.
The beam angle for the treatment of right-side breast cancer ranged from 155◦ to
172◦ counterclockwise. The starting point of the b am was between 50◦ and 60◦, while the
stopping point was between −130◦ and −150◦. For left-sided breast cancer, the beam angle
ranged from 169◦ to 190◦ clockwise. The starting point was between −45◦ and −50◦, while
the stopping point was between 124◦ and 140◦.
3.2. Pre-Treatment and Intra-Fractional CBCT
Table 1 summarizes the range of motion (ROM) in centimeters by location and RT
technique according to the x-, y-, and z-axes, as well as the absolute difference. For all
locations and treatment techniques, larger ROMs were recorded for pre-treatment CBCT
scan than for the corresponding intra-fractional CBCT scan. All comparisons of the absolute
differences between pre-treatment CBCT and intra-fractional CBCT scan were statistically
significant (p < 0.001). Therefore, the magnitude of the positional change is likely to be
smaller on intra-fractional CBCT than on inter-fractional CBCT, regardless of location or
the technique used.
However, even though intra-fractional movement was less than its inter-fractional coun-
terpart, there remain a few exceptions regarding significant positional changes. Figure 2A–D
summarizes the intra-fractional ROM in right-sided breast cancer patients. Figure 3A–D
displays the intra-fractional ROM in left-sided breast cancer patients treated using the
DIBH technique. Figure 4A–D shows the intra-fractional ROM in left-sided breast cancer
patients treated using CPAP. The means and standard deviations of intra-fractional ROM
were 0.16 cm and 0.09 for the right breast, 0.25 cm and 0.14 for the left breast with the use of
DIBH, and 0.27 cm and 0.15 for the left breast with the use of CPAP. Significant differences
were found between left-sided breast cancer patients treated using the DIBH technique
and right-sided breast cancer patients (p < 0.001) and between left-sided breast cancer
patients treated using CPAP and right-sided breast cancer patients (p < 0.001); however, no
statistically significant difference was observed between left-sided breast cancer patients
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treated using the DIBH technique versus left-sided breast cancer patients treated using
CPAP (p = 0.094).
Table 1. Range of motion according to treatment location and radiotherapy technique.
x-Axis y-Axis z-Axis AbsoluteDifference
Treatment Location and
Radiotherapy Technique Median (Range) Median (Range) Median (Range) Median (Range)
Rt. breast pre-treatment
CBCT, Free-breathing (cm) −0.07 (−0.78–0.64) 0.14 (−2.92–1.30) 0.29 (−1.69–0.94) 0.53 (0.06–2.98)
Rt. breast intra-fractional
CBCT, Free-breathing (cm) −0.01 (−0.42–0.36) 0.00 (−0.32–0.49) 0.06 (−0.34–0.50) 0.14 (0.00–0.62)
Lt. breast pre-treatment
CBCT, DIBH (cm) 0.12 (−1.32–0.84) -0.03 (−1.86–4.26) 0.29 (−1.97–1.83) 0.66 (0.08–4.41)
Lt. breast intra-fractional
CBCT, DIBH (cm) 0.00 (−0.63–0.50) -0.01 (−0.62–0.81) 0.03 (−0.50–0.80) 0.23 (0.02–0.96)
Lt. breast pre-treatment
CBCT, CPAP (cm) 0.03 (−1.83–1.41) 0.00 (−3.72–3.18) 0.07 (−1.92–1.50) 0.69 (0.04–3.80)
Lt. breast intra-fractional
CBCT, CPAP (cm) 0.01 (−1.11–0.71) 0.03 (−0.70–0.50) 0.09 (−0.46–0.60) 0.24 (0.00–1.15)
CBCT, cone-beam computed tomography; CPAP, continuous positive airway pressure; DIBH, deep-inspiration breath hold.
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Figure 2. Intra-fractional range of motion for right-sided breast cancer patients. Waterfall plots
depicting the intra-fractional positional deviation regarding movements on the (A) x-axis, (B) y-axis,
and (C) z-axis and the (D) absolute difference.
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Figure 4. Intra-fractional range of motion for left-sided breast cancer patients using continuous
positive airway pressure. Waterfall plots depicting the intra-fractional positional deviation regarding
movements on the (A) x-axis, (B) y-axis, and (C) z-axis and the (D) absolute difference.
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3.3. Dose-Volume Histogram Analysis
Table 2 summarizes the DVH parameters for the original plan and the modified plan
reflecting intra-fractional movements of 10 selected patients. Although these cases were
unusual due to their large variations in movement, notable differences were reported in
target volume coverage and (increased) radiation doses to OARs. As described in the
Methods, 90% was the minimum dose coverage to the target area in terms of D95% of the PTV
and V95% of the prescription dose. According to the modified plan, seven patients did not meet
the minimum requirement, and the target coverage in these cases was deemed insufficient
according to our institutional criteria. Patient 1 and Patient 3, whose treatment plans had
been considered to be ideal in the original settings, demonstrated a downshift toward the
acceptable range. In one extreme case of left-sided breast cancer treated using the DIBH
technique, Patient 5 experienced a large decrease in D95% of the PTV from 94.03% to 80.45%.
Patients 4 and 7 experienced a more than 20-fold increase in the V25 Gy to the heart in
modified plans compared to that in the original plans. Figure 5 displays the exemplary
cases of insufficient dose coverage to the target volume and a case of increased dose to
the lung.
Table 2. Summary of changes in dose-volume histogram values between the original plan and modified plan.
Patients (Location;
Technique)
D95% of the PTV
(% of Prescribed
Dose)
V95% of the prescribed dose















Original 96.1 96.9 9.53 56.07 12.15 24.49 0.51
Modified 94.9 95 9.05 55.33 10.9 22.21 0.48
Patient 2
(Right-sided)
Original 95.47 95.83 8.23 45.27 11.2 14.15 0
Modified 86.03 87.41 7.01 42.52 8 12.86 0
Patient 3
(Right-sided)
Original 98.02 99 11.05 73.1 13.44 23.61 0.62
Modified 93.53 94 9.82 71.38 9.78 21.57 0.18
Patient 4 (Left-sided;
DIBH)
Original 96.77 97.28 8.01 34.81 12.37 21.39 0.15
Modified 86.88 88.41 9.68 40.24 15.71 31.62 3.32
Patient 5 (Left-sided;
DIBH)
Original 94.03 93.54 6.27 38.31 5.95 11.71 0
Modified 80.45 81.55 5.75 38.2 3.85 10.87 0
Patient 6 (Left-sided;
DIBH)
Original 94.76 94.88 8.43 57.51 8.84 19.02 0.01
Modified 86.41 83.64 10.05 61.73 12.64 22.35 0.36
Patient 7 (Left-sided;
DIBH)
Original 91.67 90.02 9.67 62.38 11.57 26.35 1.48
Modified 87.26 88.07 9.75 64.93 11.53 32.41 3.87
Patient 8 (Left-sided;
CPAP)
Original 95.75 96.25 7.89 43.06 11.25 14.39 0
Modified 90.3 89.02 6.61 39.66 8.09 13.16 0
Patient 9 (Left-sided;
CPAP)
Original 93.19 92.43 7.83 41.44 11.27 13.74 0
Modified 90.52 90.62 9.39 45.37 14.92 14.75 0.02
Patient10(Left-sided;
CPAP)
Original 93.77 93.4 8 41.66 11.55 16.09 0
Modified 90.44 89.6 7.08 39.18 9.27 15.52 0
CPAP, continuous positive airway pressure; PTV, planning target volume; DIBH, deep-inspiration breath hold.
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Figure 5. Modification of the plan reflecting the intra-fractional movement resulted in deviation of some key dosimetric parameters
in selected cases. In figure (A), the dark green an red ar as i icate the volumes receiving 100% and 95% of the prescribed dose,
respectively. No ark green or red area is shown in figure (B). Blue arrows indicate V95% of the prescription dose in figure (A,B), with
respective values of 95.83% and 87.41%. In another case, the lung volume receiving 20 Gy is shown by the pink-colored area (C) and is
enlarged in figure (D), suggesting unnecessary exposure of the normal lung to radiation.
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4. Discussion
This study showed the extent of pre-treatment and intra-fractional movement among
breast cancer patients receiving IMRT. Our study results suggest that the inter-fractional
variation is greater than the intra-fractional variation, thereby strengthening the argument
that image-guided verification is necessary before each fraction of treatment. However,
intra-fractional movement should not be neglected as the positional deviation during RT
could result in suboptimal radiation delivery. This phenomenon was more prominent in
left-sided breast cancer than in right-sided breast cancer, according to the results of the
current study.
This phenomenon may have been due to the effect of the additional techniques used to
avoid normal organ toxicity. The DIBH technique requires patients to hold their breath in a
deep inspirational state to inflate the lungs. However, this technique could be physically
demanding for some patients [12]. The repetition of this possibly strenuous task of breath
holding could lead to extensive internal organ movement. The question concerning the
DIBH technique is whether its ability to increase the distance between OARs and the RT
target is offset by an unacceptable ROM for the target volume. Although there is a paucity of
data, a few studies have reported acceptable ROM of the heart periphery during DIBH [13],
and the reproducibility of the breast area has been confirmed by surface imaging [14]. These
outcomes are in concordance with the results of our study. We showed a median variation
of 0.00 cm, −0.01 cm, 0.03 cm in the x-, y-, and z-axes, respectively. Another method
used for normal organ sparing in left-sided breast radiation is CPAP. A study reported the
effect of CPAP in left-sided breast cancer patients preparing for RT, showing an increase
in lung volume by 60% and a decrease in heart volume by 12% [15]. These CPAP effects
are beneficial in preventing radiation-induced toxicity in the heart and the lungs; however,
its effect on internal movements during a treatment session is questionable. In our study,
those treated with CPAP showed median intra-fractional movements of 0.01 cm, 0.03 cm,
and 0.09 cm in the x-, y-, and z-axes, respectively; these values were mostly within the
acceptable ROMs. However, both patients treated using the DIBH and CPAP techniques
demonstrated wider intra-fractional ROMs than free-breathing right-sided breast cancer
patients. Considering the commonly cited side effects of CPAP that cause poor compliance,
such as rhinitis, nasal congestion, and aerophagia [16], the discomfort induced by CPAP
may contribute to larger ROMs during RT.
The introduction of IMRT and SBRT in the field of radiation therapy opens up a
new era of RT with endless possibilities. In this study, we specifically used VMAT which
could provide conformal dose distribution in a short beam-on time by adjusting gantry
speed, dose rate, and multi-leaf collimator [17]. The pace at which innovations develop is
faster than ever. Concurrently with the improvement of RT techniques, there have been
developments that reduce RT volumes, and high-dose per fraction regimens can target
many primary or metastatic tumor sites [18]. This trend also applies to breast cancer [19],
which has a long history of treatment with radiation. For selected ductal carcinoma in
situ or early-stage breast cancer patients, PBI using external beam radiotherapy is now
becoming an attractive alternative to whole-breast irradiation (WBI) with non-inferior
oncologic outcomes [20,21]. Even for WBI, a recent phase III trial showed non-inferior
local tumor control with 26 Gy in 5 fractions compared to 40 Gy in 15 fractions [22]. These
trials could be characterized by extreme hypofractionation with a larger dose per fraction.
This suggests a transition of treatment duration from the conventional 7 weeks to less
than 2 weeks. Unlike conventional RT regimens with multiple fractions that could negate
non-systematic error in few fractions, the error in each fraction would have had more
significance in these hypofractionated settings. Thus, proper verification before each
treatment should be guaranteed in the modern RT era. The most common way to verify
the RT target volume and adjacent OARs is image-guided RT with volumetric imaging
modalities. Even though portal imaging or kV planar imaging is used more frequently
than volumetric imaging for the breast [2], some studies have reported the efficacy of
CBCT in reducing the planning target volume with minimal setup uncertainties [23,24].
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Therefore, the utilization of volumetric imaging verification in breast cancer patients could
become more common in the near future. With this perspective, we examined volumetric
CBCT images from breast cancer patients who underwent IMRT not only for pre-treatment
verification but also for the measurement of intra-fractional movement.
Even though pre-treatment verification to reduce inter-fractional variation is becom-
ing more common, anatomical information during actual beam delivery is not routinely
acquired in clinical settings. However, compared to conventional RT, modern RT requires
many sophisticated techniques and utilizes numerous beams, which lead to an increased
duration of treatment. Therefore, intra-fractional variation as well as inter-fractional vari-
ation could be affected. Long treatment times could induce unnecessary motion at the
patient’s end. The concept of intra-fractional verification was investigated in multiple
studies regarding various organs. One study about SBRT for lung tumors showed that
intra-fractional CBCT revealed a maximal target shift of 5.7, 3.6, and 4.9 mm along the
anterior-posterior, left-right, and superior-inferior axes, respectively. This meant that an
expansion equal to or greater than 7 mm from the gross tumor volume was enough to deal
with intra-fractional movement during SBRT for lung tumors with a delivery time of up
to 4 min [5]. Another study using an anthropomorphic thorax phantom that evaluated
the efficacy of CBCT scans reconstructed from kV images acquired simultaneously during
SBRT delivery showed that these scans could help identify the dominant position of tumors
during RT delivery [25]. The prostate is also an organ of interest due to its intra-fractional
motion during radiotherapy. Many studies have measured intra-fractional movement by
comparing pre-treatment CBCT and immediately post-treatment CBCT scans rather than
by acquiring simultaneous images. Those studies showed minimal movement of the target
area in various treatment settings. For example, one study revealed a movement of only
0.4 mm of the prostate bed during postoperative or salvage RT [26] and a movement of less
than 3 mm in patients receiving IMRT after 125I implantation according to fiducial-based
imaging [27]. For breast cancer patients, the optical surface image was used frequently to
evaluate intra-fractional motion during RT. A study with 104 patients and 2028 fractions of
RT using an optical surface scanner demonstrated intra-fractional deviation of less than
5 mm in breast RT [28]. However, unlike surface scanning which can only estimate the
exact movement of the skin surface, CBCT has a relative advantage as it can assess not
only the skin surface but also the relative position of internal structures such as the heart,
lungs, bony structures, and chest wall. Thus, CBCT could provide different outcomes
compared to skin surface imaging. We identified a study using pre-treatment CBCT and
post-treatment CBCT in patients receiving PBI, which suggested the significant effect of
intra-fractional errors even with a 10 mm setup margin [29]. A systematic literature review
on intra-fractional motion during RT in breast cancer patients reported that although the
range of intra-fractional movement in these patients was mostly less than 5 mm, some
individuals showed large variations [30]. Even though the review predominantly included
studies investigating two-dimensional tangential images, unlike ours in which CBCT im-
ages were acquired simultaneously with actual beam delivery, the results from the review
are in concordance with our findings.
In our study, most cases showed acceptable intra-fractional deviation with a median of
less than 3 mm in terms of absolute distance from the initial isocenter. However, although
it is plausible to believe that intra-fractional movement does not cause severe deviations
in the majority of cases, there were cases involving low target volume coverage or an
increased dose to OARs. Coinciding with the current trend of hypofractionation and
smaller target volumes, insufficient dose coverage, even in a single fraction, could result in
nonoptimal treatment outcomes. For instance, the impact of a reduction in D95% of the PTV
from 94% to 80% in one fraction during the treatment period, seen in our study, would
obviously be larger in patients receiving 25 Gy in 5 fractions than in patients receiving
50.4 Gy in 28 fractions. Adequate set-up margin or prompt adaptive planning according
to the result of intra-fractional CBCT might be helpful. Especially in VMAT planning,
using virtual bolus is another option because it could compensate for internal positional
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or anatomic change during the course of radiotherapy with better coverage of the target
volume [31]. Additionally, cases involving a more than 20-fold increase in V25 Gy of the
heart were reported. According to the widely accepted guideline, it is recommended to
keep the V25 Gy of the heart at less than 10% to reduce the cardiac mortality risk to less than
1% [32]. Even though the results of our study did not violate the safety criteria for V25 Gy of
the heart, watchful observation for OARs is required during RT planning. Specifically, as
mentioned above, left-sided breast cancer patients showed an increased likelihood of larger
intra-fractional motion, although outliers were reported for both left- and right-sided breast
cancer patients. Similar outcomes were reported earlier with a large isocenter variation
that considerable affected dosimetric outcomes in a few cases of left-sided breast cancer
patients treated using the DIBH technique [33].
Intra-fractional optimization was not possible with intra-fractional CBCT as the final
reconstructed images were available only after the treatment. Nevertheless, given that
studies analyzing intra-fractional CBCT images in breast cancer patients are scarce, our re-
search has the relative strength by providing quantitative results about the intra-fractional
motion and following changes in dosimetric outcomes in selected cases. The limitations
of this study include the substandard quality of intra-fractional CBCT scans compared to
that of pre-treatment CBCT scans. As intra-fractional CBCT scans are acquired simultane-
ously with the delivery of treatment beams, beam scattering and subsequent worsening
of image quality are unavoidable [34]. However, it is still possible to discriminate sig-
nificant landmark organs such as the lung, heart, and thoracic wall on intra-fractional
CBCT. Considering their possible use in marker-less positional verification and tumor
tracking in lung cancer patients [35,36], the quality of intra-fractional CBCT images seems
to be acceptable in clinical settings. Moreover, further refinement in CBCT image quality
was achieved by utilizing binary moving-blocker-based scatter correction [37]. Another
limitation was that an extra dose was delivered to the patient for acquiring intra-fractional
CBCT images. However, compared to the high RT dose used for treatment, the additional
dose was minimal. Additionally, it is arguable that the set-up margin of our institution is
rather too small, and a bigger set-up margin could resolve issues related to the movement
of the target and OARs. Still, given that Asian women tend to have denser and smaller
breasts compared to the Western population [38,39], a small set-up margin was preferable
to avoid skin toxicity.
5. Conclusions
In conclusion, this study reported quantitative measurements of inter-fractional and
intra-fractional errors in breast cancer patients receiving RT. Pre-treatment CBCT showed
larger variations than intra-fractional CBCT, and the range of intra-fractional motion was
likely to be bigger in left-sided breast cancer patients using DIBH or CPAP. Even though
the intra-fractional ROM was minimal in most cases, few cases showed huge variations
that could significantly affect the goal of RT. Therefore, based on the data provided above,
the intra-fractional movement might be taken into consideration in specific circumstances
when it could be substantial, and even a single non-systematic error could negatively affect
treatment outcomes.
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